{"product_id":"medical-device-manufacturing-kpi-metrics","title":"7 Critical KPIs to Measure for Medical Device Manufacturing","description":"\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"line_top\"\u003e\u003c\/div\u003e\n\u003ch2\u003eKPI Metrics for Medical Device Manufacturing\u003c\/h2\u003e\n\u003cp\u003eMedical Device Manufacturing demands rigorous financial and operational tracking due to high regulatory hurdles and long sales cycles Focus on 7 core KPIs across quality, production efficiency, and profitability Your initial capital expenditure (CAPEX) is high, totaling $1,115,000 for equipment like the Advanced CNC Machining Center and Cleanroom Setup in 2026 You must track Gross Margin %—which should target above 60%—and ensure your Quality Assurance Overhead remains low, such as the 04% allocated for Surgical Staplers Review these metrics weekly for production KPIs and monthly for financial results to manage the high fixed annual operating costs of about $142 million in 2026\n\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\" id=\"main_article_image\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #6067F2;\"\u003e7 KPIs to Track for \u003c\/span\u003eMedical Device Manufacturing\u003c\/h2\u003e\u003cbr\u003e\n\u003ctable id=\"dwnld_tbl_id\"\u003e\n\u003ctr\u003e\n\u003cth\u003e#\u003c\/th\u003e\n\u003cth\u003eKPI Name\u003c\/th\u003e\n\u003cth\u003eMetric Type\u003c\/th\u003e\n\u003cth\u003eTarget \/ Benchmark\u003c\/th\u003e\n\u003cth\u003eReview Frequency\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003ctd\u003eGross Margin Percentage (GM%)\u003c\/td\u003e\n\u003ctd\u003eMeasures product profitability; calculated as (Revenue - COGS) \/ Revenue\u003c\/td\u003e\n\u003ctd\u003eTarget should be above 60% given high R\u0026amp;D and regulatory costs\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2\u003c\/td\u003e\n\u003ctd\u003eFirst Pass Yield (FPY)\u003c\/td\u003e\n\u003ctd\u003eMeasures manufacturing efficiency and quality; calculated as good units produced \/ total units started\u003c\/td\u003e\n\u003ctd\u003eTarget should be 98% or higher to minimize expensive rework\u003c\/td\u003e\n\u003ctd\u003eDaily\/Weekly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3\u003c\/td\u003e\n\u003ctd\u003eNon-Conformance Report (NCR) Rate\u003c\/td\u003e\n\u003ctd\u003eMeasures product defects and compliance risk; calculated as total NCRs raised \/ total units produced\u003c\/td\u003e\n\u003ctd\u003eAim for less than 05%\u003c\/td\u003e\n\u003ctd\u003eWeekly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e4\u003c\/td\u003e\n\u003ctd\u003eCost of Goods Sold (COGS) Per Unit\u003c\/td\u003e\n\u003ctd\u003eTracks the total direct and indirect cost of manufacturing one item\u003c\/td\u003e\n\u003ctd\u003eCalculated by summing all unit costs (e.g., $50 for Surgical Stapler in 2026) plus allocated overhead\u003c\/td\u003e\n\u003ctd\u003eQuarterly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e5\u003c\/td\u003e\n\u003ctd\u003eCustomer Acquisition Cost (CAC)\u003c\/td\u003e\n\u003ctd\u003eMeasures the cost to secure a new hospital or distributor contract\u003c\/td\u003e\n\u003ctd\u003eCalculated as Sales \u0026amp; Marketing expenses \/ new customers acquired; must be significantly lower than Lifetime Value (LTV)\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6\u003c\/td\u003e\n\u003ctd\u003eInventory Turnover Ratio\u003c\/td\u003e\n\u003ctd\u003eMeasures how fast inventory sells; calculated as COGS \/ Average Inventory\u003c\/td\u003e\n\u003ctd\u003eTarget depends on product type, but aim for 3–6 turns annually to avoid obsolescence\u003c\/td\u003e\n\u003ctd\u003eMonthly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7\u003c\/td\u003e\n\u003ctd\u003eEBITDA Margin %\u003c\/td\u003e\n\u003ctd\u003eMeasures core operating profitability before interest, taxes, depreciation, and amortization\u003c\/td\u003e\n\u003ctd\u003eTarget should rise from 20%+ in early years (2026 EBITDA is $3123M) to 30%+ long-term\u003c\/td\u003e\n\u003ctd\u003eQuarterly\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"dwnld_btn_div\"\u003e\u003cbutton id=\"dwnld_btn_id\" class=\"dwnld_btn_clss\"\u003eDownload Table in XLSX\u003c\/button\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e \u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhich metrics best predict future revenue growth and market penetration?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003ePredicting future revenue for Medical Device Manufacturing hinges on analyzing the revenue contribution from high-value versus volume products, tracking pipeline conversion rates, and measuring penetration against the Total Addressable Market (TAM). Understanding your initial capital needs, which you can estimate by reviewing \u003ca href=\"\/blogs\/startup-costs\/medical-device-manufacturing\"\u003eWhat Is The Estimated Cost To Open And Launch Your Medical Device Manufacturing Business?\u003c\/a\u003e, sets the baseline for these growth targets.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eProduct Mix Value Drivers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack the revenue split between high-value items, like the Endoscope Camera, versus high-volume staples, like the Surgical Stapler.\u003c\/li\u003e\n\u003cli\u003eIf the high-value item carries a \u003cstrong\u003e60% gross margin\u003c\/strong\u003e and the volume item only \u003cstrong\u003e30%\u003c\/strong\u003e, growth is better signaled by margin dollars than unit count.\u003c\/li\u003e\n\u003cli\u003eMonitor the adoption rate of new, higher-priced diagnostic equipment versus established surgical tools.\u003c\/li\u003e\n\u003cli\u003eA shift toward lower-margin products, even with higher unit sales, signals future pressure on profitability.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eMarket Capture Velocity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eCalculate Total Addressable Market (TAM) penetration monthly; if your TAM is \u003cstrong\u003e$4 billion\u003c\/strong\u003e, hitting \u003cstrong\u003e0.5% penetration\u003c\/strong\u003e is a key milestone.\u003c\/li\u003e\n\u003cli\u003ePipeline conversion rates show if you can defintely capture that potential market share.\u003c\/li\u003e\n\u003cli\u003eMeasure the time it takes for a qualified hospital lead to place a first order, aiming for under \u003cstrong\u003e90 days\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eA \u003cstrong\u003e25% conversion rate\u003c\/strong\u003e from initial demo to closed sale is a strong indicator of sales efficiency.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eHow do we accurately isolate the true cost of quality and regulatory compliance?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eAccurately isolating quality and compliance costs means splitting fixed regulatory overhead, like the \u003cstrong\u003e$10,000\/month\u003c\/strong\u003e consulting fee, from direct unit costs, otherwise, your operating margin looks artificially high. This separation is vital for understanding true unit economics, a key factor when assessing \u003ca href=\"\/blogs\/profitability\/medical-device-manufacturing\"\u003eIs The Medical Device Manufacturing Business Achieving Sustainable Profitability?\u003c\/a\u003e\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eSeparate Fixed vs. Variable Quality Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eMove Warranty Reserve from direct Cost of Goods Sold (COGS) to an operating expense accrual.\u003c\/li\u003e\n\u003cli\u003eTreat Post-Market Surveillance (PMS) as a fixed overhead, not a per-unit cost.\u003c\/li\u003e\n\u003cli\u003eThis reveals the \u003cstrong\u003etrue variable cost\u003c\/strong\u003e of producing one device.\u003c\/li\u003e\n\u003cli\u003eFailing to separate these inflates your gross margin calculation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eImpact of Fixed Regulatory Spend\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eThe \u003cstrong\u003e$10,000 monthly\u003c\/strong\u003e regulatory consulting fee is fixed overhead.\u003c\/li\u003e\n\u003cli\u003eThis fee directly reduces operating margin before sales volume is considered.\u003c\/li\u003e\n\u003cli\u003eCost drivers include complexity of new device filings and audit frequency.\u003c\/li\u003e\n\u003cli\u003eIf you only ship \u003cstrong\u003e500 units\u003c\/strong\u003e, that fee is $20 per unit impact, defintely skewing analysis.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eAre our manufacturing processes efficient enough to handle the forecasted 5-year unit growth?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eYour ability to handle 5-year unit growth hinges entirely on the current utilization of your CNC Machining Center and the efficiency gains you lock in via yield rate improvements. If cycle time reduction isn't baked into the next 18 months, you'll hit a hard capacity wall before Year 3.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCapacity Check: Assets and Time\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack production cycle time monthly; aim to cut the \u003cstrong\u003e4-day\u003c\/strong\u003e average by \u003cstrong\u003e10%\u003c\/strong\u003e annually.\u003c\/li\u003e\n\u003cli\u003eCurrent yield rate sits at \u003cstrong\u003e88%\u003c\/strong\u003e; hitting \u003cstrong\u003e92%\u003c\/strong\u003e by Q4 2024 frees up capacity equivalent to one extra machine.\u003c\/li\u003e\n\u003cli\u003eThe CNC Machining Center is running at \u003cstrong\u003e85% utilization\u003c\/strong\u003e; anything above \u003cstrong\u003e90%\u003c\/strong\u003e signals immediate need for CAPEX review.\u003c\/li\u003e\n\u003cli\u003eFocus on reducing scrap; every point gained in yield directly lowers the effective labor cost per good unit.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eLabor Efficiency and Growth Planning\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eDefine labor hours per unit; if it takes \u003cstrong\u003e6 hours\u003c\/strong\u003e now, scaling requires dropping that to \u003cstrong\u003e4.5 hours\u003c\/strong\u003e to absorb volume.\u003c\/li\u003e\n\u003cli\u003eIf onboarding new staff takes \u003cstrong\u003e14+ days\u003c\/strong\u003e, churn risk rises significantly during expansion phases.\u003c\/li\u003e\n\u003cli\u003eReviewing the initial investment for scaling production is key; see \u003ca href=\"\/blogs\/startup-costs\/medical-device-manufacturing\"\u003eWhat Is The Estimated Cost To Open And Launch Your Medical Device Manufacturing Business?\u003c\/a\u003e for upfront planning.\u003c\/li\u003e\n\u003cli\u003eWe defintely need to model the cost impact of a \u003cstrong\u003e20%\u003c\/strong\u003e volume increase on direct labor overhead.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhat is the minimum cash runway needed to absorb regulatory delays or major equipment failure?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eYou need a minimum cash buffer of \u003cstrong\u003e$1097 million\u003c\/strong\u003e to safely cover operational burn while managing the significant \u003cstrong\u003e$1115 million\u003c\/strong\u003e initial capital expenditure (CAPEX) and potential regulatory setbacks; this is critical before you even start scaling production, so Have You Considered The Regulatory Requirements For Launching Your Medical Device Manufacturing Business? Monitoring your accounts receivable (AR) days is the next immediate liquidity check.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCovering the Burn\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eThe \u003cstrong\u003e$1097 million\u003c\/strong\u003e figure represents your required cash cushion.\u003c\/li\u003e\n\u003cli\u003eThis must absorb delays before revenue hits.\u003c\/li\u003e\n\u003cli\u003eCalculate monthly net burn rate precisely.\u003c\/li\u003e\n\u003cli\u003eIf regulatory approval takes 18 months, you need 18 months of operating cash ready.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eLiquidity Stress Test\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eThe \u003cstrong\u003e$1115 million\u003c\/strong\u003e initial CAPEX drains liquidity fast.\u003c\/li\u003e\n\u003cli\u003eAssess how long that CAPEX lasts against the burn.\u003c\/li\u003e\n\u003cli\u003eMonitor AR days; slow payments erode runway defintely.\u003c\/li\u003e\n\u003cli\u003eEquipment failure requires immediate access to replacement funds.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e \u003cdiv class=\"card_smpl\"\u003e\n\n\u003cdiv class=\"double_border\"\u003e\n\n\u003cdiv class=\"card_smpl_header\"\u003e\n\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\n\u003ch3\u003eKey Takeaways\u003c\/h3\u003e\n\n\u003c\/div\u003e\n\n\u003cul class=\"lst_crct_blog\"\u003e\n\n\u003cli\u003eAchieving a Gross Margin Percentage above 60% is crucial to absorb the high R\u0026amp;D and regulatory costs inherent in medical device manufacturing.\u003c\/li\u003e\n\n\u003cli\u003eManufacturing efficiency must be rigorously maintained, targeting a First Pass Yield (FPY) of 98% or higher to minimize costly rework and compliance failures.\u003c\/li\u003e\n\n\u003cli\u003eManaging the substantial initial capital expenditure of $1,115,000 and high annual fixed operating costs requires tight monitoring of EBITDA margins and cash runway.\u003c\/li\u003e\n\n\u003cli\u003eTo successfully handle forecasted unit growth, operational metrics like production cycle time and capacity utilization of CAPEX assets must be tracked weekly.\u003c\/li\u003e\n\n\u003c\/ul\u003e\n\n\u003c\/div\u003e\n\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 1\n: \u003cspan style=\"color: #126CFF;\"\u003eGross Margin Percentage (GM%)\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eGross Margin Percentage (GM%) shows how much money you keep from sales after paying for the direct costs of making the product. It tells you the core profitability of your devices before overhead like sales or R\u0026amp;D hits. For a medical device maker, this number is critical for covering those heavy regulatory and development expenses.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eShows true product pricing power.\u003c\/li\u003e\n\u003cli\u003eFunds high R\u0026amp;D and compliance costs.\u003c\/li\u003e\n\u003cli\u003eProvides cushion against material price hikes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIgnores fixed overhead like SG\u0026amp;A.\u003c\/li\u003e\n\u003cli\u003eCan mask inefficient production processes.\u003c\/li\u003e\n\u003cli\u003eDoesn't account for inventory obsolescence risk.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor medical device manufacturing, your target GM% must be \u003cstrong\u003eabove 60%\u003c\/strong\u003e. This high threshold exists because you carry significant, non-negotiable costs like clinical trials and FDA compliance filings. If your GM% dips below this level, you likely aren't covering your necessary long-term investment in innovation, defintely not if you plan to launch new tech on schedule.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eNegotiate better pricing on raw materials.\u003c\/li\u003e\n\u003cli\u003eIncrease production volume to lower per-unit overhead allocation.\u003c\/li\u003e\n\u003cli\u003eRaise the sales price on newer, high-value diagnostic equipment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate Gross Margin Percentage by taking your revenue, subtracting the Cost of Goods Sold (COGS), and dividing that result by the total revenue. This gives you the percentage of every dollar that remains to pay for everything else.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003eGross Margin Percentage = (Revenue - COGS) \/ Revenue\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSay you sell $1,000,000 worth of surgical tools (Revenue) and the direct costs—materials, direct labor, and manufacturing overhead—total $350,000 (COGS). Your gross profit is $650,000. We check if this meets the 60% target.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e($1,000,000 - $350,000) \/ $1,000,000 = \u003cstrong\u003e65%\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eReview GM% \u003cstrong\u003emonthly\u003c\/strong\u003e, not quarterly.\u003c\/li\u003e\n\u003cli\u003eTrack COGS changes tied to specific product SKUs.\u003c\/li\u003e\n\u003cli\u003eEnsure R\u0026amp;D costs are correctly excluded from COGS.\u003c\/li\u003e\n\u003cli\u003eIf First Pass Yield drops, expect immediate negative pressure on this metric.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 2\n: \u003cspan style=\"color: #126CFF;\"\u003eFirst Pass Yield (FPY)\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFirst Pass Yield (FPY) tells you how efficient your manufacturing line is right now. It measures the percentage of units that pass quality checks the very first time they come off the line, without needing any fixes or rework. For a medical device manufacturer like us, this metric is critical because rework isn't just expensive; it adds compliance risk. We need to aim for \u003cstrong\u003e98%\u003c\/strong\u003e or higher consistently.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eDirectly lowers the \u003cstrong\u003eCost of Goods Sold (COGS) Per Unit\u003c\/strong\u003e by avoiding costly scrap and labor hours spent fixing errors.\u003c\/li\u003e\n\u003cli\u003eIncreases production throughput, meaning we ship finished diagnostic equipment faster to hospitals.\u003c\/li\u003e\n\u003cli\u003eSignals process stability, which is essential when dealing with FDA oversight and device quality mandates.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eFPY doesn't tell you why units failed; it only flags the failure event.\u003c\/li\u003e\n\u003cli\u003eIt can hide systemic issues if the initial inspection criteria are set too loosely.\u003c\/li\u003e\n\u003cli\u003eIt ignores downstream costs, like inventory holding costs for units waiting for rework.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIn high-precision fields like medical device manufacturing, a target FPY of \u003cstrong\u003e98%\u003c\/strong\u003e is the baseline expectation. Anything below that means you are defintely losing money on every batch due to unnecessary labor and material waste. For complex surgical tools, top performers often push this above \u003cstrong\u003e99.5%\u003c\/strong\u003e because the cost of a single failure in the field is catastrophic to reputation and liability.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eStandardize operator training and enforce strict adherence to Standard Operating Procedures (SOPs) for every assembly step.\u003c\/li\u003e\n\u003cli\u003eInvest capital in better process controls or automated inspection equipment at known failure points.\u003c\/li\u003e\n\u003cli\u003eImmediately link any unit failing FPY to a Non-Conformance Report (NCR) to drive root cause analysis.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate FPY by dividing the number of units that pass quality checks immediately by the total number of units that entered the process. This shows the efficiency of your initial manufacturing run before any secondary operations are needed.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nFPY = (Total Units Started - Units Requiring Rework) \/ Total Units Started\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSay we ran a batch of \u003cstrong\u003e5,000\u003c\/strong\u003e diagnostic units this morning. After the first inspection, we found \u003cstrong\u003e150\u003c\/strong\u003e units needed adjustments due to minor calibration issues. We plug those figures into the formula to see our efficiency.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nFPY = (5,000 - 150) \/ 5,000 = 4,850 \/ 5,000 = 0.97 or \u003cstrong\u003e97%\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cp\u003eSince this result is below our \u003cstrong\u003e98%\u003c\/strong\u003e target, we know we need to review the calibration process immediately to prevent future rework.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack FPY by production line and shift; look for variance greater than \u003cstrong\u003e1%\u003c\/strong\u003e between shifts.\u003c\/li\u003e\n\u003cli\u003eReview FPY data daily, linking dips to specific material batches or machine maintenance logs.\u003c\/li\u003e\n\u003cli\u003eEnsure operators understand that rework labor directly impacts the \u003cstrong\u003eGross Margin Percentage\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eIf FPY drops below \u003cstrong\u003e95%\u003c\/strong\u003e for three consecutive days, halt production for a process review.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 3\n: \u003cspan style=\"color: #126CFF;\"\u003eNon-Conformance Report (NCR) Rate\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThe Non-Conformance Report (NCR) Rate shows how often your manufactured medical devices fail quality checks. It’s a direct measure of product defects and compliance risk. For a manufacturer like Precision Health Dynamics, keeping this number low is essential for patient safety and avoiding regulatory fines.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003ePinpoint specific production lines causing defects.\u003c\/li\u003e\n\u003cli\u003eLower costs associated with scrap and rework.\u003c\/li\u003e\n\u003cli\u003eMaintain compliance with quality system regulations.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eA low rate might hide severe, high-impact failures.\u003c\/li\u003e\n\u003cli\u003eReporting delays mean you react late to quality slips.\u003c\/li\u003e\n\u003cli\u003eIt doesn't measure the cost of the non-conformance itself.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor high-reliability manufacturing, especially medical devices, the target NCR Rate should be extremely low. The goal here is \u003cstrong\u003eless than 0.5%\u003c\/strong\u003e. If you are seeing rates above 1.0%, you are defintely leaving money on the table through excessive rework or facing serious compliance scrutiny from bodies like the Food and Drug Administration (FDA).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTighten supplier quality agreements for raw materials.\u003c\/li\u003e\n\u003cli\u003eMandate immediate Root Cause Analysis (RCA) for every NCR.\u003c\/li\u003e\n\u003cli\u003eInvest in better tooling calibration schedules.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate this metric by dividing the total number of quality issues logged by the total output for that period. This gives you the percentage of units that required corrective action before release.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nNCR Rate = Total NCRs Raised \/ Total Units Produced\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf your facility produced \u003cstrong\u003e15,000\u003c\/strong\u003e surgical tools last week and logged \u003cstrong\u003e50\u003c\/strong\u003e Non-Conformance Reports, here’s the quick math:\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nNCR Rate = 50 NCRs \/ 15,000 Units Produced = 0.0033 or \u003cstrong\u003e0.33%\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cp\u003eThis result of 0.33% is below the 0.5% target, showing good control over the production floor that week.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eReview this metric \u003cstrong\u003eevery week\u003c\/strong\u003e, not monthly.\u003c\/li\u003e\n\u003cli\u003eSegment the rate by specific product SKU for focus.\u003c\/li\u003e\n\u003cli\u003eTrack the time taken from NCR creation to final disposition.\u003c\/li\u003e\n\u003cli\u003eEnsure the definition of a 'unit produced' is crystal clear across shifts.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 4\n: \u003cspan style=\"color: #126CFF;\"\u003eCost of Goods Sold (COGS) Per Unit\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eCost of Goods Sold (COGS) Per Unit tells you exactly what it costs to manufacture a single medical device, like a Surgical Stapler. This figure bundles direct costs (materials, assembly labor) and necessary indirect costs (allocated overhead). Tracking this lets you see if your production process is efficient enough to hit your target \u003cstrong\u003eGross Margin Percentage\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSets the absolute minimum price needed to cover production costs.\u003c\/li\u003e\n\u003cli\u003ePinpoints when material or labor costs start eating into profit.\u003c\/li\u003e\n\u003cli\u003eDrives decisions on whether to automate or redesign components.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eAllocating overhead costs can introduce estimation bias.\u003c\/li\u003e\n\u003cli\u003eIt ignores critical non-production costs like SG\u0026amp;A.\u003c\/li\u003e\n\u003cli\u003eA low number might hide quality issues leading to high rework costs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor medical device manufacturing, COGS Per Unit must be aggressively managed because regulatory compliance and R\u0026amp;D amortization are high. While benchmarks vary wildly by device complexity, you need this number low enough to support a \u003cstrong\u003eGross Margin Percentage\u003c\/strong\u003e above \u003cstrong\u003e60%\u003c\/strong\u003e. If your COGS is too high, you won't cover the fixed costs associated with FDA clearance and clinical trials.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eBoost \u003cstrong\u003eFirst Pass Yield (FPY)\u003c\/strong\u003e above the \u003cstrong\u003e98%\u003c\/strong\u003e target to cut scrap and rework expenses.\u003c\/li\u003e\n\u003cli\u003eReview supplier contracts quarterly to lock in lower material costs for high-volume components.\u003c\/li\u003e\n\u003cli\u003eOptimize facility utilization; producing more units spreads fixed overhead costs thinner, lowering the unit cost.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eTo calculate this, sum up everything tied directly to making the product and divide by how many you made. You must review this calculation quarterly. Here’s the quick math for the formula.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nCOGS Per Unit = (Direct Materials + Direct Labor + Allocated Overhead) \/ Total Units Produced\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSay in 2026, the total cost components for one Surgical Stapler summed up to \u003cstrong\u003e$50\u003c\/strong\u003e. If your total direct costs were $35, direct labor was $10, and allocated overhead was $5, the COGS Per Unit is $50. This is the number you track against your target margin.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nCOGS Per Unit = ($35 Materials + $10 Labor + $5 Overhead) \/ 1 Unit = $50\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eAlways segregate variable manufacturing costs from fixed overhead allocation.\u003c\/li\u003e\n\u003cli\u003eCompare the current quarter's COGS Per Unit against the previous quarter's result.\u003c\/li\u003e\n\u003cli\u003eInvestigate any unit cost increase immediately; it often signals a drop in \u003cstrong\u003eFPY\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eEnsure overhead allocation methodology is defintely consistent across all product lines for fair comparison.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 5\n: \u003cspan style=\"color: #126CFF;\"\u003eCustomer Acquisition Cost (CAC)\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eCustomer Acquisition Cost (CAC) is what you spend to land one new customer, usually a hospital or distributor. For medical device sales, this metric shows how efficient your sales team and marketing efforts are at opening new accounts. You must track this \u003cstrong\u003emonthly\u003c\/strong\u003e to ensure spending doesn't outpace the value those new accounts bring.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eShows the true cost of opening a new hospital account.\u003c\/li\u003e\n\u003cli\u003eHelps set realistic Sales \u0026amp; Marketing budgets for expansion.\u003c\/li\u003e\n\u003cli\u003eDirectly informs the critical \u003cstrong\u003eLTV to CAC ratio\u003c\/strong\u003e analysis.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eLong medical device sales cycles mean CAC reflects past efforts, not current ones.\u003c\/li\u003e\n\u003cli\u003eIt often misses the true cost of regulatory approval tied to acquisition.\u003c\/li\u003e\n\u003cli\u003eIf Lifetime Value (LTV) isn't calculated correctly, a low CAC might still signal a bad investment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIn enterprise B2B sales like medical devices, CAC is naturally high due to long sales cycles and specialized personnel needed to close a hospital contract. While some industries aim for a 3:1 LTV:CAC ratio, medical device firms often tolerate higher initial CACs if the LTV (driven by recurring consumable sales or high-value equipment) justifies it. You need to know your expected contract lifespan to set a safe benchmark.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eShorten the time from initial contact to signed contract to reduce ongoing sales overhead.\u003c\/li\u003e\n\u003cli\u003eFocus sales efforts on clinics where clinicians already champion your device type.\u003c\/li\u003e\n\u003cli\u003eIncrease the \u003cstrong\u003eAverage Contract Value\u003c\/strong\u003e from new customers acquired.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv cla ss=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eTo find CAC, you divide your total Sales \u0026amp; Marketing expenses for a period by the number of new customers (hospitals or distributors) you secured in that same period. This must be reviewed monthly.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nCAC = Sales \u0026amp; Marketing Expenses \/ New Customers Acquired\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSay your Sales \u0026amp; Marketing team spent \u003cstrong\u003e$450,000\u003c\/strong\u003e in Q1 2026 on salaries, travel, and marketing materials. During that same quarter, you successfully signed \u003cstrong\u003e5\u003c\/strong\u003e new hospital systems to distribution agreements. Here’s the quick math on the resulting CAC:\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nCAC = $450,000 \/ 5 = $90,000 per new hospital contract\n\u003c\/div\u003e\n\u003cp\u003eThis means it cost you \u003cstrong\u003e$90,000\u003c\/strong\u003e in upfront effort to secure each new account. You need to confirm that the expected LTV from that hospital significantly exceeds this figure.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack CAC by acquisition channel (e.g., trade shows vs. direct sales).\u003c\/li\u003e\n\u003cli\u003eRecalculate LTV:CAC ratio monthly to catch negative trends early.\u003c\/li\u003e\n\u003cli\u003eEnsure all costs associated with initial product installation are included in S\u0026amp;M.\u003c\/li\u003e\n\u003cli\u003eIf onboarding takes 14+ days, churn risk rises defintely.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 6\n: \u003cspan style=\"color: #126CFF;\"\u003eInventory Turnover Ratio\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThe Inventory Turnover Ratio shows how many times you sell and replace your stock over a specific period, usually a year. For a medical device manufacturer, this metric is critical because holding specialized surgical tools or diagnostic components too long risks obsolescence due to rapid technological change. It’s a key measure of how effectively you manage your working capital.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIdentifies slow-moving inventory before it becomes unsellable or expired.\u003c\/li\u003e\n\u003cli\u003eIndicates efficiency in managing high-value, regulated components.\u003c\/li\u003e\n\u003cli\u003eFrees up cash that is otherwise tied up in warehouse storage costs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eA ratio that is too high suggests frequent stockouts, risking hospital supply continuity.\u003c\/li\u003e\n\u003cli\u003eIt ignores the specific costs associated with regulatory testing for each batch.\u003c\/li\u003e\n\u003cli\u003eIt doesn't differentiate between raw materials and finished goods inventory values.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor medical device manufacturing, the target turnover rate depends heavily on the product lifecycle, which is often long for capital equipment but short for consumables. You should aim for \u003cstrong\u003e3 to 6 turns annually\u003c\/strong\u003e to balance holding costs against the risk of technological or regulatory obsolescence. If your rate falls below 3, you’re likely tying up too much cash in inventory.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTighten production schedules to match hospital purchasing cycles better.\u003c\/li\u003e\n\u003cli\u003eFocus on improving \u003cstrong\u003eFirst Pass Yield (FPY)\u003c\/strong\u003e to reduce the COGS component.\u003c\/li\u003e\n\u003cli\u003eUse direct sales data to forecast demand accurately, minimizing safety stock buffers.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou calculate this by dividing your total Cost of Goods Sold for the period by the average value of inventory held during that same period.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003eInventory Turnover Ratio = Cost of Goods Sold (COGS) \/ Average Inventory\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eSuppose your total Cost of Goods Sold for the year was $15,000,000, and after averaging the beginning and ending inventory values, you held $3,000,000 in stock on average. Here’s the quick math to see how fast that inventory moved.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003eInventory Turnover Ratio = $15,000,000 \/ $3,000,000 = 5.0 Turns\u003c\/div\u003e\n\u003cp\u003eA result of 5.0 means you sold through your average inventory level five times last year. What this estimate hides is the specific turnover rate for high-cost surgical tools versus low-cost disposables.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eReview this ratio \u003cstrong\u003emonthly\u003c\/strong\u003e, matching the required operational cadence.\u003c\/li\u003e\n\u003cli\u003eEnsure inventory valuation is based on the \u003cstrong\u003eCOGS Per Unit\u003c\/strong\u003e figures you track quarterly.\u003c\/li\u003e\n\u003cli\u003eIf you see a dip, check the \u003cstrong\u003eNon-Conformance Report (NCR) Rate\u003c\/strong\u003e immediately for quality issues.\u003c\/li\u003e\n\u003cli\u003eIt’s defintely better to hold less inventory when dealing with complex, regulated devices.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003eKPI 7\n: \u003cspan style=\"color: #126CFF;\"\u003eEBITDA Margin %\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDefinition\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eEBITDA Margin Percentage measures your core operating profitability. It strips out interest, taxes, depreciation, and amortization (EBITDA) to show how well the actual business operations generate cash before financing and accounting decisions. For a medical device manufacturer, this metric shows the efficiency of production and sales execution, separate from financing structure.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eAdvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eHelps compare operational efficiency across different capital structures.\u003c\/li\u003e\n\u003cli\u003eIsolates the performance of the core manufacturing and sales engine.\u003c\/li\u003e\n\u003cli\u003eTracks progress toward long-term profitability goals, independent of asset age.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-minus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eDisadvantages\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eIgnores necessary capital expenditures (CapEx) for replacing machinery.\u003c\/li\u003e\n\u003cli\u003eCan mask poor working capital management or inventory issues.\u003c\/li\u003e\n\u003cli\u003eDoesn't account for tax liabilities or debt servicing costs required for survival.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eIndustry Benchmarks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFor medical device manufacturing, early-stage margins often sit around \u003cstrong\u003e20%\u003c\/strong\u003e due to high initial R\u0026amp;D and regulatory hurdles required to get surgical tools approved. The goal is to push this above \u003cstrong\u003e30%\u003c\/strong\u003e as scale is achieved and fixed overhead spreads over higher revenue volume. Hitting these targets proves the business model is sustainable outside of initial investment phases.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-rocket-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Improve\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eDrive Gross Margin up by optimizing material sourcing or negotiating better pricing for high-volume sales contracts.\u003c\/li\u003e\n\u003cli\u003eControl Selling, General, and Administrative (SG\u0026amp;A) expenses tightly as revenue scales, ensuring overhead doesn't outpace sales growth.\u003c\/li\u003e\n\u003cli\u003eFocus on hitting production targets to spread fixed overhead costs across more units, improving operating leverage.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eHow To Calculate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eTo find your EBITDA Margin Percentage, you take your Earnings Before Interest, Taxes, Depreciation, and Amortization and divide it by your total Revenue for the period.\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nEBITDA Margin % = EBITDA \/ Revenue\n\u003c\/div\u003e\n\u003cbr\u003e\n\u003cbr\u003e\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-how-calc-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eExample of Calculation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf you are targeting the early-stage goal, you look at the projected 2026 EBITDA, which is stated at \u003cstrong\u003e$3,123M\u003c\/strong\u003e. To hit the minimum \u003cstrong\u003e20%\u003c\/strong\u003e margin target, you must generate enough revenue to support that EBITDA figure. Here’s the quick math to find the implied revenue base for that year:\u003c\/p\u003e\n\u003cdiv class=\"card_smpl_formula\"\u003e\nImplied Revenue = $3,123M \/ 0.20 = $15,615M\n\u003c\/div\u003e\n\u003cp\u003eIf your actual revenue in 2026 lands at $15,615M, your EBITDA margin is exactly 20%. If revenue is higher, your margin improves; if lower, you miss the target.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e  \n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\u003ch3\u003eTips and Trics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eReview this metric quarterly, as mandated, to catch margin erosion early.\u003c\/li\u003e\n\u003cli\u003eWatch SG\u0026amp;A growth relative to revenue growth; it must slow down as you scale.\u003c\/li\u003e\n\u003cli\u003eEnsure depreciation schedules don't mask true operational cash flow needs for equipment replacement.\u003c\/li\u003e\n\u003cli\u003eBenchmark your \u003cstrong\u003e30%+\u003c\/strong\u003e long-term goal against established, scaled device makers; defintely aim h\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e","brand":"FinancialModelsLab","offers":[{"title":"Default Title","offer_id":49303861395699,"sku":"medical-device-manufacturing-kpi-metrics","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0522\/6191\/2762\/files\/medical-device-manufacturing-kpi-metrics.webp?v=1782686686","url":"https:\/\/financialmodelslab.com\/products\/medical-device-manufacturing-kpi-metrics","provider":"Financial Models Lab","version":"1.0","type":"link"}